Abstract:The mRNA and protein expression of HSP70 were studied using RT-PCR and FCM techniques. It's immune protective effects in vivo and the cytotoxicity in vitro were also observed. Results showed that cell viability didn't change under 42 similar to 43 degrees C, but declined in 44 similar to 45 degrees C; the level of HSP70 mRNA decreased initially (0.5 similar to 4.0 hour) but gradually resumed and increased from 8 to 12 hours at 42 degrees C. The positive cells expressed membrane HSP70 were significantly higher in heat shocked group than in a control group (P<0.001); the highest positive rate was 96.8% at 43 degrees C. The C3H mice immunized with heat shocked H22 cells could resist a secondary subcutaneous inoculation of parental H22 cells and their tumorigenic rate was significantly lower than that in mice immunized with parental H22 cells and RPMI 1640 control mice, which were 1/9,7/8 and 8/8,respectively. Their median survival time was also longer than that of parental cell group and RPMI 1640 control group, which were >90 days, 73.5 days, and 39.5 days, respectively. Through heat-treated tumor cell and lymphocyte mixed culture (TLMC), the induced lymphocytes had higher cytotoxic activities than that of splenic cells. The cytotoxicity against H22 cells reached 65.38% (2 hrs, 42 degrees C) and 67.84% (12 hrs, 43 degrees C) and could be blocked by anti-HSP70 McAb. Phenotype analysis revealed that the rate of TCR gamma delta(+) cells rose with increasing cytotoxic activity, but no similar changes could be found in the CD4+CD8+TCR alpha beta(+) subset. These results suggest that proper heat shock conditions can improve the immunogenicity of tumor cells and CD4- CD8- TCR gamma delta(+)T carried on cytotoxic function via the HSP70 molecule.

PROGRESS OF STUDY ON THE RELATIONSHIP BETWEEN HEAT SHOCK PROTEIN 70 AND TUMOR

Recent Advances in Heat Shock Protein-Based Cancer Vaccines

Progress of Study on Heat Shock Proteins

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70

Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity

The multifunction of HSP70 in cancer: Guardian or traitor to the survival of tumor cells and the next potential therapeutic target

Membrane heat shock protein 70: a theranostic target for cancer therapy

Heat Shock Protein–Peptide and HSP-Based Immunotherapies for the Treatment of Cancer

Clinicopathologic significance of heat shock protein 60 as a survival predictor in breast carcinoma

The Study on the Expression of Membrane HSP70 Protein in H22 Cell and Its Immunoprotective Mechanism Against Carcinoma.

HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances

Functional and therapeutic significant of heat-shock protein 90 (HSP90) in reproductive cancers

Targeting Heat-Shock Protein 90 in Cancer: An Update on Combination Therapy

A 14-mer Peptide from HSP70 Protein is the Critical Epitope Which Enhances NK Activity Against Tumor Cells in vivo

The Expression of Heat Shock Protein 70/90 in Patients with Atrophic Gastritis or Gastric Cancer and Its Significance

Heat Shock Proteins at the Crossroads Between Cancer and Alzheimer’s Disease

Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis

Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo.

The HSP70 gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer

Tumor-derived Hsp70-CD14 interaction enhances the antitumor potential of cytotoxic T cells by activating tumor-associated macrophages to express CC chemokines and CD40 costimulatory molecules

Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential